Janssen Sues Sandoz Over Alzheimer's Drug ANDA
The complaint filed in the U.S. District Court for the District of New Jersey alleges Sandoz’s ANDA filing with the U.S. Food and Drug Administration infringes on a patent held by Janssen LLP, a Johnson & Johnson unit.
Sandoz allegedly intends to bring to market a generic version of galantamine hydrobromide...
Already a subscriber? Click here to login